Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2861887 | 1.00 | TSHR (0.48) | TSHRALDH1A1PLA2G2CHPGD | |
| SCHEMBL7575927 | 0.94 | TSHR (0.48) | TSHRALDH1A1PLA2G2C | |
| SCHEMBL5434048 | 0.94 | TSHR (0.48) | TSHRALDH1A1PLA2G2C | |
| SCHEMBL9785959 | 0.93 | TSHR (0.52) | TSHRALDH1A1PLA2G2C | |
| SCHEMBL5449337 | 0.93 | TSHR (0.52) | TSHRALDH1A1PLA2G2C | |
| SCHEMBL876481 | 0.90 | TSHR (0.44) | TSHRALDH1A1 | |
| SCHEMBL876483 | 0.90 | TSHR (0.44) | TSHRALDH1A1 | |
| SCHEMBL10536751 | 0.86 | TSHR (0.35) | TSHRALDH1A1 | |
| SCHEMBL5873976 | 0.84 | FAAH (0.46) | — | |
| SCHEMBL10955085 | 0.84 | TSHR (0.33) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7728180-B2 | Method for producing ethers | KURARAY CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20080262272-A1 | Method For Producing Ethers | KURARAY CO., LTD. (JP) | 2008-10-23 | — | — | US | disclosed |
| EP-1760061-A1 | METHOD FOR PRODUCING ETHERS | KURARAY CO., LTD. (JP) | 2007-03-07 | — | — | EP | disclosed |
| US-7026523-B2 | Method for telomerizing non-cyclic olefins | OXENO OLEFINCHEMIE GMBH (DE) | 2006-04-11 | — | — | US | disclosed |
| US-20050038273-A1 | Method for telomerizing non-cyclic olefins | OXENO OLEFINCHEMIE GMBH (DE) | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038273-A1 | Method for telomerizing non-cyclic olefins | PCNA, TELO2, TTI1 | TSHR 3017/4885ALDH1A1 3141/4885PLA2G2C 3771/4885 |
| US-20080262272-A1 | Method For Producing Ethers | TELO2, PDS5A, TERT | TSHR 657/4885ALDH1A1 3068/4885PLA2G2C 3333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.